<DOC>
	<DOCNO>NCT02026752</DOCNO>
	<brief_summary>The objective obtain plasma sample Human Immunodeficiency Virus Type 1 ( HIV-1 ) infect individual viral load across dynamic range Aptima HIV-1 assay . The plasma sample test method comparison study support approval Aptima HIV-1 assay Gen-Probe 's Panther testing system . The objective method comparison study evaluate clinical utility Aptima HIV-1 assay compare result FDA-licensed COBAS assay ( Roche Molecular Systems , Inc. , Branchburg , New Jersey ) plasma sample viral load across dynamic range Aptima HIV-1 assay .</brief_summary>
	<brief_title>Collection Samples From HIV-1 Infected Individuals Evaluation Aptima HIV-1 Assay</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria The subject document HIV infection The subject least 15 year age time enrollment For ART subject , subject document HIV1 RNA level low limit quantitation FDAapproved assay sample collect past 90 day . The subject ( and/or legally authorize representative , allow ) willing able provide write informed consent provide specimen ( minor need document consent his/her parent legal guardian , unless site institutional review board [ IRB ] approve waiver parental consent minor ) . Exclusion Criteria A potential subject ineligible study subject , clinician , medical record report follow : Subject 's HIV disease stage and/or current ART status unknown . It unknown current previous ART change stop due therapy failure . For nonART subject , subject previously ART past 30 day Subject already participate study subject 's previous sample ( ) provide withdrawn ( ie , subject evaluable sample study ) Subject history illness principal investigator ( PI ) designee considers could interfere affect conduct , result , and/or completion study Subject history illness PI designee considers could create unacceptable risk subject enrol study</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>